A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis

NCT00550446 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

386

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Adalimumab
DRUG: CP-690-550
DRUG: CP-690-550
DRUG: CP-690-550
DRUG: CP-690,550
DRUG: CP-690,550
DRUG: Placebo

Sponsor

Pfizer